CDRH Gets Specific About RF Cardiac Ablation Indications At RAPS
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to issue a new guidance on general versus specific indications and product labeling, according to CDRH Office of Device Evaluation Director Daniel Schultz